Receptor occupancy by flow cytometry

被引：10
|
作者：
Litwin, Virginia [1 ]
Green, Cherie [2 ]
Stewart, Jennifer J. [3 ]
机构：
[1] Covance Cent Lab Serv, Hematol Flow Cytometry, New York, NY 10010 USA
[2] Genentech Inc, Cytometry Biomarkers Dev Sci, San Francisco, CA 94080 USA
[3] Flow Contract Site Lab, Bothell, WA 98012 USA
来源：
CYTOMETRY PART B-CLINICAL CYTOMETRY | 2016年 / 90卷 / 02期
关键词：
DRUG DEVELOPMENT; VALIDATION;
D O I：
10.1002/cyto.b.21364
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：108 / 109
页数：2
相关论文
共 50 条
  • [1] Strategies on Assessment of Receptor Occupancy via Flow Cytometry
    Wong, A. S.
    Patel, M.
    Poirier, M.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2021, 40 (01) : 80 - 81
  • [2] Flow cytometry and receptor occupancy in immune-oncology
    Audia, Alessandra
    Bannish, Gregory
    Bunting, Rachel
    Riveley, Chelsea
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (01) : 87 - 94
  • [3] Role of receptor occupancy assays by flow cytometry in drug development
    Stewart, Jennifer J.
    Green, Cherie L.
    Jones, Nicholas
    Liang, Meina
    Xu, Yuanxin
    Wilkins, Danice E. C.
    Moulard, Maxime
    Czechowska, Kamila
    Lanham, David
    McCloskey, Thomas W.
    Ferbas, John
    van der Strate, Barry. W. A.
    Hogerkorp, Carl-Magnus
    Wyant, Timothy
    Lackey, Alan
    Litwin, Virginia
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (02) : 110 - 116
  • [4] Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development
    Liang, Meina
    Schwickart, Martin
    Schneider, Amy K.
    Vainshtein, Inna
    Del Nagro, Christopher
    Standifer, Nathan
    Roskos, Lorin K.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (02) : 117 - 127
  • [5] Recommendations for the development and validation of flow cytometry-based receptor occupancy assays
    Green, Cherie L.
    Stewart, Jennifer J.
    Hogerkorp, Carl-Magnus
    Lackey, Alan
    Jones, Nicholas
    Liang, Meina
    Xu, Yuanxin
    Ferbas, John
    Moulard, Maxime
    Czechowska, Kamila
    Mc Closkey, Thomas W.
    van der Strate, Barry W. A.
    Wilkins, Danice E. C.
    Lanham, David
    Wyant, Timothy
    Litwin, Virginia
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (02) : 141 - 149
  • [6] Best practices for optimization and validation of flow cytometry-based receptor occupancy assays
    Hilt, Ed
    Sun, Yongliang S.
    McCloskey, Thomas W.
    Eck, Steve
    McIntosh, Thomas
    Grugan, Katharine D.
    Lanham, David F.
    Standifer, Nathan
    Green, Cherie
    Litwin, Virginia
    Stewart, Jennifer J.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2021, 100 (01) : 63 - 71
  • [7] Expanding the Clinical Cytometry Toolbox-Receptor Occupancy by Mass Cytometry
    Huse, Kanutte
    CYTOMETRY PART A, 2019, 95 (10) : 1046 - 1048
  • [8] Effect of antagonists on GPIIb/IIIa receptor occupancy: use of a whole blood flow cytometry assay
    Besson, I
    McGregor, JL
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2711 - P2711
  • [9] How validated receptor occupancy flow cytometry assays can impact decisions and support drug development
    Moulard, Maxime
    Ozoux, Marie-Laure
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (02) : 150 - 158
  • [10] GLUCOCORTICOID RECEPTOR ANALYSIS BY FLOW-CYTOMETRY
    VAN, NT
    BARLOGIE, B
    KOBAYASHI, Y
    BLUMENSCHEIN, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 202 - 202
12345